RonaldBNataleMD

Oncology • West Hollywood, CA

Professor of Medicine, University Mich Medical School

Join to view full profile

Dr. Natale is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Natale's full profile

Already have an account?

Office
8700 Beverly Blvd
#Ac1042b
West Hollywood, CA 90048
Phone+1 310-423-1101

Fax+1 310-659-3928

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1977 - 1980
Wayne State University School of MedicineResidency, Internal Medicine, 1974 - 1976
Wayne State University School of MedicineClass of 1974

Certifications & Licensure

NY State Medical License 1978 - Present
CA State Medical License 1993 - 2024
MI State Medical License Active through 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:LA Area Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors:Southern California Castle Connolly, 2012
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2002 Nov 01
Completed
Phase 3
Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC Start of enrollment: 2006 Jan 01
Unknown status
Phase 1, Phase 2
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Feb 01
Terminated
Phase 3
Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Start of enrollment: 2011 Jan 11
Terminated
Phase 3
Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease Start of enrollment: 2012 Jul 01
Completed
Phase 1
A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants Start of enrollment: 2013 Aug 01
Completed
Phase 2
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Active, not recruiting
Phase 3
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer Start of enrollment: 2020 May 28
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

368 citations
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124
Primo N. Lara, Ronald B. Natale, John Crowley, Heinz-Josef Lenz, Mary W. Redman
Journal of Clinical Oncology. 2009-05-20
1933 citations
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, V. O. Speights, Nicholas J. Vogelzang
The New England Journal of Medicine. 2003-08-28
2088 citations
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial
Mark G. Kris, Ronald B. Natale, Roy S. Herbst, Thomas J. Lynch, Diane Prager
JAMA. 2003-10-22

Journal Articles

Predictive Biomarkers for Response to EGFR-Directed Monoclonal Antibodies for Advanced Squamous Cell Lung Cancer
D R Spigel, E S Kim, S S Ramalingam, M A Socinski, C Obasaju, C J Langer, R B Natale, P D Bonomi, H Wakelee, Annals of Oncology

Press Mentions

Cancer Nearly Gone for Redondo Beach Mayor Bill BrandMay 28th, 2021

Grant Support

Core--Clinical Investigations Support FacilityNational Cancer Institute1996–2000
Southwest Oncology GroupNational Cancer Institute1995–1996
Southwest Oncology GroupNational Cancer Institute1985–1993
Testing The Predictions Of A Human Tumor Cloning AssayNational Cancer Institute1985–1987

Other Languages

Italian